Zhenwei W. Peng - Publications

Correction: Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.

Journal: Oncogene

Published: August 05, 2026

Preoperative MRI features for predicting response to postoperative adjuvant anti-PD-1 therapy in hepatocellular carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 27, 2025

Wavelength-division-multiplexed and identical -weak Bragg grating arrays in multicore fiber for single-channel OFDR shape sensing.

Journal: Optics express

Published: November 11, 2025

Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study.

Journal: Journal of gastroenterology

Published: November 06, 2025

Corrigendum to "Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth"[Cancer Lett. 503 (2021) 1-10.].

Journal: Cancer letters

Published: October 18, 2025

Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study.

Journal: Liver cancer

Published: September 21, 2025

Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization.

Journal: Radiology. Imaging cancer

Published: September 05, 2025

High-spatial-resolution 2D shape sensing based on OFDR using adaptive spectrum method with narrow sweep range.

Journal: Optics express

Published: July 30, 2025

Corrigendum to "Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner" [Cancer Lett. (460), 28 September 2019, Pages 29-40].

Journal: Cancer letters

Published: July 18, 2025

Erratum: Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6-methyladenosine mRNA methylation-dependent mechanism.

Journal: Hepatology (Baltimore, Md.)

Published: July 18, 2025

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204).

Journal: Hepatology (Baltimore, Md.)

Published: July 13, 2025

Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: July 10, 2025